Nan Lin
department
Hepatobiliary Surgery
Introduction

Nan Lin, MD

?

Titles

Associate Professor of?Hepatobiliary Surgery Department

?

Research Interests

Surgical treatment of liver cancer

Surgical treatment of portal hypertension

Surgical treatment of hepatic, biliary, pancreatic and splenic diseases

The pathogenesis of hepatocellular carcinoma

He has been engaged in clinical and basic research work of primary liver cancer for many years. He accumulated rich clinical experience in surgery treatment and radiofrequency ablation of liver cancer. Over the years, he was involved in the MSC (mesenchymal stem cell) treatment for liver fibrosis and got the National Science Foundation for Young Scholars of China?in 2010.

?

Education and Experience

Work Experience

2000.12-2005.12 ?Resident, General Surgery, The third affiliated hospital of Sun Yat-Sen University

2005.12-2010.11: Visiting staff, General Surgery, The third affiliated hospital of Sun Yat-Sen University

2010.12-now: associate senior doctor, Hepatobiliary Surgery Department, The third affiliated hospital of Sun Yat-Sen University

?

Certifications

2005.09-2008.07: Doctor Degree, Surgery, Sun Yat-sen University

· 2000.0 Master Degree, Surgery, Sun Yat-sen University

1995.09-2000.07: Bachelor degree, Clinical medicine, Sun Yat-sen University

?

Honors and Awards

1. 2010 National Science Foundation for Young Scholars of China

2. 2011 Natural Science Foundation of Guangdong Province

?

Publications

1?Lin Nan, Hu Kupeng, Chen SiXie S, Tang Z, Lin Jizong, Xu Ruiyun*. Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells. Life Sci, 85(7-8): 291-5. 2009.IF2.527.

2 Lin Nan,?Chen S, Pan W, Xu L, Hu K,?Xu Ruiyun*. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats. Am J Physiol Cell Physiol. 301(2): C469-77. 2011.?(IF:3.536)

3?Lin Nan,?Tang Z, Deng M, Zhong Y, Lin Jizong,Yang X, Xiang P, Xu Ruiyun. Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun, 372(1):260-265.?2008IF2.484

4?Lin Nan,?LinJizong,Liu boPan weidong,chen si, Xu Ruiyun*?Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold . Cell proliferation 43.427-434. 2010IF2.527

5 Chen S, Xu L,?Lin Nan, Pan W, Hu K, Xu Ruiyun*?Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells. Life Sci. 89(25-26): 975-81.?2011.IF2.527

6 Zhong Yuesi, Lin Nan,?Deng M, Zhang F, Tang Z, Xu Ruiyun*.?Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver. Dig Dis Sci, 55(2): 438-45. 2010IF2.117

7 Lin NanLiu Bo, Xu Ruiyun, Deng Meihai Splenectomy with endoscopic variceal ligation is superior to sple-centomy with pericardial devascularization in treatment of portal hypertension. World Jourmal of Gastroenterology ,12(45):7375-7379.?2006IF2.471

8?Nan lin, Xu linan, Xu jianglian, Human bone marrow mesenchymal stem cells over-exprssing α-melanocyte-stimulating hormone gene reverses carbon tetrachloride induced liver fibrosis in mice?. Hepatology.?56(4, suppl):777A (Abstract)?2012IF11.665

?

Contact

Department of Hepatobiliary Surgery, Third Affiliated Hospital of Sun Yat-Sen University

NO.600 TianHe road, Guangzhou city, 510630, Guangdong province, China

Email:drdmh@medmail.com.cn

Fax: 86-20-85253178.

Appointment Phone: 1331881889